Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder — Stella

Recruiting

Back to Autism Spectrum Disorder trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

National Institutes of Health Clinical Center, Bethesda, Maryland

Key details

Sponsor

National Institute of Mental Health (NIMH)

Enrollment target

~106 participants

Started

June 2021

Primary completion

June 2027

Age range

11 Years – 25 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov